Cargando…
Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters
BACKGROUND AND PURPOSE: 4‐Methyl‐N‐methylcathinone (mephedrone) is a synthetic stimulant that acts as a substrate‐type releaser at transporters for dopamine (DAT), noradrenaline (NET) and 5‐HT (SERT). Upon systemic administration, mephedrone is metabolized to several phase I compounds: the N‐demethy...
Autores principales: | Mayer, F P, Wimmer, L, Dillon‐Carter, O, Partilla, J S, Burchardt, N V, Mihovilovic, M D, Baumann, M H, Sitte, H H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978154/ https://www.ncbi.nlm.nih.gov/pubmed/27391165 http://dx.doi.org/10.1111/bph.13547 |
Ejemplares similares
-
Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro
por: Niello, Marco, et al.
Publicado: (2021) -
Probing the Selectivity of Monoamine Transporter Substrates by Means of Molecular Modeling
por: Seddik, Amir, et al.
Publicado: (2013) -
Evidence for a Role of Transporter-Mediated Currents in the Depletion of Brain Serotonin Induced by Serotonin Transporter Substrates
por: Baumann, Michael H, et al.
Publicado: (2014) -
Amphetamines, new psychoactive drugs and the monoamine transporter cycle
por: Sitte, Harald H., et al.
Publicado: (2014) -
Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters()
por: Hofmaier, Tina, et al.
Publicado: (2014)